228 related articles for article (PubMed ID: 21508164)
1. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.
Karlsson J; Andréasson B; Kondori N; Erman E; Riesbeck K; Hogevik H; Wennerås C
Clin Vaccine Immunol; 2011 Jun; 18(6):969-77. PubMed ID: 21508164
[TBL] [Abstract][Full Text] [Related]
2. Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.
Karlsson J; Roalfe L; Hogevik H; Zancolli M; Andréasson B; Goldblatt D; Wennerås C
Clin Vaccine Immunol; 2016 Apr; 23(4):379-85. PubMed ID: 26912783
[TBL] [Abstract][Full Text] [Related]
3. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
Mailankody S; Landgren O
Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
[TBL] [Abstract][Full Text] [Related]
5. CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Neumann F; Pfreundschuh M; Preuss KD; Schormann C; Zwick C; Murawski N; Kubuschok B
Int J Cancer; 2015 Sep; 137(5):1076-84. PubMed ID: 25677163
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.
Bosseboeuf A; Feron D; Tallet A; Rossi C; Charlier C; Garderet L; Caillot D; Moreau P; Cardó-Vila M; Pasqualini R; Arap W; Nelson AD; Wilson BS; Perreault H; Piver E; Weigel P; Girodon F; Harb J; Bigot-Corbel E; Hermouet S
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978808
[TBL] [Abstract][Full Text] [Related]
8. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammopathies of undetermined significance called "MGUS"].
Clément F
Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Haematologica; 2012 Jun; 97(6):854-8. PubMed ID: 22180421
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiology of monoclonal gammopathies].
Hurez D
Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
14. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.
Bosseboeuf A; Seillier C; Mennesson N; Allain-Maillet S; Fourny M; Tallet A; Piver E; Lehours P; Mégraud F; Berthelot L; Harb J; Bigot-Corbel E; Hermouet S
Front Immunol; 2020; 11():854. PubMed ID: 32536913
[TBL] [Abstract][Full Text] [Related]
16. T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
San Miguel JF; Caballero MD; Gonzalez M
Am J Hematol; 1985 Nov; 20(3):267-73. PubMed ID: 3933332
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
18. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
19. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
Waldenström JG
Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
[No Abstract] [Full Text] [Related]
20. Detection of anti-histone activity in sera of patients with monoclonal gammopathies.
Shoenfeld Y; el-Roeiy A; Ben-Yehuda O; Pick AI
Clin Immunol Immunopathol; 1987 Feb; 42(2):250-8. PubMed ID: 3100119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
